Russell Investments Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,882
Closed -$24.8M 3000
2022
Q3
$24.8M Buy
100,882
+78,787
+357% +$21.3M 0.05% 418
2022
Q2
$5.59M Buy
22,095
+1,430
+7% +$386K 0.01% 1043
2022
Q1
$6.81M Sell
20,665
-4,676
-18% -$1.44M 0.01% 994
2021
Q4
$9.13M Buy
25,341
+382
+2% +$129K 0.01% 942
2021
Q3
$8.18M Buy
24,959
+2,497
+11% +$846K 0.01% 985
2021
Q2
$7.02M Sell
22,462
-9,898
-31% -$3.04M 0.01% 1136
2021
Q1
$10.2M Buy
32,360
+268
+0.8% +$85.8K 0.02% 931
2020
Q4
$10.4M Sell
32,092
-13,018
-29% -$3.6M 0.02% 835
2020
Q3
$12.4M Sell
45,110
-3,469
-7% -$999K 0.03% 659
2020
Q2
$11.7M Buy
48,579
+33,475
+222% +$6.72M 0.03% 666
2020
Q1
$2.24M Sell
15,104
-4,525
-23% -$751K 0.01% 1408
2019
Q4
$3.3M Buy
19,629
+1,385
+8% +$257K 0.01% 1450
2019
Q3
$3.21M Sell
18,244
-1,764
-9% -$381K 0.01% 1424
2019
Q2
$5.15M Buy
20,008
+11,058
+124% +$2.93M 0.01% 1206
2019
Q1
$2.55M Sell
8,950
-1,085
-11% -$361K ﹤0.01% 1592
2018
Q4
$3.25M Sell
10,035
-18,284
-65% -$6.35M 0.01% 1344
2018
Q3
$12.7M Sell
28,319
-7,558
-21% -$2.98M 0.02% 803
2018
Q2
$14.8M Sell
35,877
-44,974
-56% -$16.3M 0.03% 689
2018
Q1
$23.5M Sell
80,851
-3,244
-4% -$822K 0.04% 532
2017
Q4
$16M Buy
84,095
+34,598
+70% +$6.46M 0.03% 753
2017
Q3
$8.35M Buy
49,497
+842
+2% +$127K 0.01% 1036
2017
Q2
$6.97M Sell
48,655
-176,710
-78% -$23.7M 0.01% 1068
2017
Q1
$28.2M Sell
225,365
-57,555
-20% -$6.67M 0.05% 438
2016
Q4
$32.1M Buy
+282,920
New +$32.8M 0.06% 382

Other funds holding ABMD

Russell Investments Group's ABMD Position: Q4 2022 in Review

Russell Investments Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 100,882 shares — an estimated $24.8M sold.

Russell Investments Group first reported a position in ABMD in Q4 2016 and held it in 24 quarters. The position peaked at $32.1M in Q4 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Russell Investments Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 100,882 Abiomed Inc shares in Q4 2022, an estimated $24.8M.
  • Russell Investments Group first reported a position in Abiomed Inc in Q4 2016 and held it in 24 quarters.
  • Russell Investments Group's Abiomed Inc position peaked at $32.1M in Q4 2016.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.